ESC 365 - Copeptin plasma level in type 1 and type 2 myocardial infarctions

ESC Premium Access

Copeptin plasma level in type 1 and type 2 myocardial infarctions

Session: Poster Session 2 - Biomarkers in acute coronary syndromes

Topic: Biomarkers

Speaker: Doctor M. Kassem (Vienna, AT)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Mona Kassem

Wilhelminen Hospital, Vienna (Austria)

0 follower

9 more presentations in this session

Fibroblast growth factor-23 (FGF23), an early biomarker of sublinical kidney dysfunction, is associated with poor prognosis in acute coronary syndrome patients

Speaker: Doctor T. Yndigegn (Lund, SE)

Physical exercise induces coronary artery collateral growth and affects cardiovascular biomarkers: A biomarker sub-analysis of the EXCITE trial

Speaker: Professor M. Lichtenauer (Salzburg, AT)

Direct comparison of the 0/1h- and 0/3h-algorithm for early rule-out of acute myocardial infarction

Speaker: Associate Professor P. Badertscher (Basel, CH)

The association of biological markers of inflammation with the severity of cardiofibrosis in patients with ST-segment elevation myocardial infarction

Speaker: Professor O. Barbarash (Kemerovo, RU)

Validation of limb leads in localizing culprit artery in inferior STEMI

Speaker: Doctor A. Smith (Biloxi, US)

Access the full session

Poster Session 2 - Biomarkers in acute coronary syndromes

Speakers: Doctor M. Kassem, Doctor T. Yndigegn, Professor M. Lichtenauer, Associate Professor P. Badertscher, Professor O. Barbarash...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources